Endurance RP Limited
Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders;… Read more
Endurance RP Limited (RPGLF) - Total Assets
Latest total assets as of June 2025: $734.00K USD
Based on the latest financial reports, Endurance RP Limited (RPGLF) holds total assets worth $734.00K USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Endurance RP Limited - Total Assets Trend (2001–2024)
This chart illustrates how Endurance RP Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Endurance RP Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Endurance RP Limited's total assets of $734.00K consist of 98.6% current assets and 1.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 21.6% |
| Accounts Receivable | $53.00K | 8.7% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2001–2024)
This chart illustrates how Endurance RP Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Endurance RP Limited's current assets represent 98.6% of total assets in 2024, an increase from 8.8% in 2001.
- Cash Position: Cash and equivalents constituted 21.6% of total assets in 2024, up from 5.8% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 8.7% of total assets.
Endurance RP Limited Competitors by Total Assets
Key competitors of Endurance RP Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Endurance RP Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Endurance RP Limited generates 1.18x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Endurance RP Limited is currently not profitable relative to its asset base.
Endurance RP Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.15 | 0.22 | 0.23 |
| Quick Ratio | 0.15 | 0.10 | 0.36 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-4.15 Million | $ -2.83 Million | $ -5.69 Million |
Endurance RP Limited - Advanced Valuation Insights
This section examines the relationship between Endurance RP Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.95 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -78.2% |
| Total Assets | $609.74K |
| Market Capitalization | $64.42K USD |
Valuation Analysis
Below Book Valuation: The market values Endurance RP Limited's assets below their book value (0.11 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Endurance RP Limited's assets decreased by 78.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Endurance RP Limited (2001–2024)
The table below shows the annual total assets of Endurance RP Limited from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $609.74K | -78.18% |
| 2023-12-31 | $2.79 Million | -89.38% |
| 2022-12-31 | $26.32 Million | -57.71% |
| 2021-12-31 | $62.23 Million | -22.51% |
| 2020-12-31 | $80.31 Million | -6.92% |
| 2019-12-31 | $86.28 Million | -40.40% |
| 2018-12-31 | $144.76 Million | -19.05% |
| 2017-12-31 | $178.83 Million | -13.41% |
| 2016-12-31 | $206.52 Million | +382.13% |
| 2015-12-31 | $42.84 Million | -18.12% |
| 2014-12-31 | $52.31 Million | -16.48% |
| 2013-12-31 | $62.64 Million | -58.75% |
| 2012-12-31 | $151.86 Million | -26.45% |
| 2011-12-31 | $206.49 Million | -31.41% |
| 2010-12-31 | $301.04 Million | +29.07% |
| 2009-12-31 | $233.23 Million | +4.27% |
| 2008-12-31 | $223.67 Million | +421.42% |
| 2006-12-31 | $42.90 Million | +19.49% |
| 2005-12-31 | $35.90 Million | -31.26% |
| 2004-12-31 | $52.23 Million | -46.91% |
| 2003-12-31 | $98.38 Million | +11.97% |
| 2002-12-31 | $87.86 Million | -7.86% |
| 2001-12-31 | $95.35 Million | -- |